Explores the historical aspects of drug development, regulatory agencies, and ethical principles in pharmacology, emphasizing the importance of informed consent and human subject protection.
Explores the selection and rationale of preclinical animal models in drug development, emphasizing the 10 to 15-year path to a marketed small-molecule drug.
Explores the challenges of inferring epidemiological parameters from clinical data, focusing on COVID-19 and the complexities of estimating infection fatality ratios.